Najafi et al., 2018 - Google Patents
Poly (N‐isopropylacrylamide): physicochemical properties and biomedical applicationsNajafi et al., 2018
View PDF- Document ID
- 6116159754536988920
- Author
- Najafi M
- Hebels E
- Hennink W
- Vermonden T
- Publication year
- Publication venue
- Temperature‐Responsive Polymers: Chemistry, Properties and Applications
External Links
Snippet
This chapter focuses on polymerization techniques, and provides examples that address Poly (N‐isopropylacrylamide)'s (PNIPAM) potential applications as biomaterial in drug and gene delivery and bioseparation. It introduces the general physicochemical properties of …
- 229920003213 poly(N-isopropyl acrylamide) 0 title abstract description 17
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
- A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
- A61K47/48215—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer, dendrimer, e.g. PEG, PPG, PEO, polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, copolymers of polyalkylene glycol or poloxamer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
- C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Najafi et al. | Poly (N‐isopropylacrylamide): physicochemical properties and biomedical applications | |
| Khutoryanskiy et al. | Temperature-responsive polymers | |
| Huang et al. | Stimuli responsive synthetic polypeptides derived from N-carboxyanhydride (NCA) polymerisation | |
| Schubert et al. | Coating matters: Review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells and organisms | |
| Ebara et al. | Smart biomaterials | |
| Johnson et al. | Poly (PEGA)-b-poly (L-lysine)-b-poly (L-histidine) hybrid vesicles for tumoral pH-triggered intracellular delivery of doxorubicin hydrochloride | |
| Yang et al. | Nano‐star‐shaped polymers for drug delivery applications | |
| Li et al. | Stimulus‐sensitive polymeric nanoparticles and their applications as drug and gene carriers | |
| Schmaljohann | Thermo-and pH-responsive polymers in drug delivery | |
| Ladmiral et al. | Polymerization-induced self-assembly of galactose-functionalized biocompatible diblock copolymers for intracellular delivery | |
| He et al. | Stimuli‐sensitive synthetic polypeptide‐based materials for drug and gene delivery | |
| Rainbolt et al. | Recent developments in micellar drug carriers featuring substituted poly (ε-caprolactone) s | |
| Deng et al. | Functional polypeptide and hybrid materials: Precision synthesis via α-amino acid N-carboxyanhydride polymerization and emerging biomedical applications | |
| Gil et al. | Stimuli-reponsive polymers and their bioconjugates | |
| Ebara et al. | Smart hydrogels | |
| Varlas et al. | Poly (sarcosine)-based nano-objects with multi-protease resistance by aqueous photoinitiated polymerization-induced self-assembly (photo-PISA) | |
| US8367051B2 (en) | Preparation of functional gel particles with a dual crosslink network | |
| Kumar et al. | Side-chain amino-acid-based ph-responsive self-assembled block copolymers for drug delivery and gene transfer | |
| KR102349029B1 (en) | Amphiphilic norbornene-based block copolymers and their molecular brushes with stimuli-responsiveness, their supramolecularly self-assembled nanostructures, and their preparation method and use thereof | |
| Qiu et al. | Polymerization‐Induced Self‐Assembly: An Emerging Tool for Generating Polymer‐Based Biohybrid Nanostructures | |
| Wang et al. | Synthesis of zwitterionic diblock copolymers with cleavable biotin groups at the junction points and fabrication of bioconjugates by biotin–streptavidin coupling | |
| Liu et al. | Zwitterionic unimolecular micelles with pH and temperature response: enhanced in vivo circulation stability and tumor therapeutic efficiency | |
| Efthimiadou et al. | Stimuli-responsive biopolymer nanocarriers for drug delivery applications | |
| Etchenausia et al. | Cationic thermoresponsive poly (N-vinylcaprolactam) microgels synthesized by emulsion polymerization using a reactive cationic macro-RAFT agent | |
| Raval et al. | Copolymers and block copolymers in drug delivery and therapy |